Abstract:Vascular smooth muscle cell (SMC) growth plays an important role in atherosclerosis, restenosis and venous bypass graft disease. With systemic drug administration no effective therapy for restenosis and venous bypass graft disease is available. This could be due to low local concentrations of the drugs at the target site. A directed delivery of drugs to tissues with a sustained release system during percutaneous transluminal coronary angioplasty (PTCA) or during bypass surgery could provide high concentrations of drugs at the target site and avoid systemic side effects. In the present study heparin was encapsulated by spray-drying into biodegradable poly(D, L-lactic-co-glycolic acid) (PLGA) to obtain a system for prolonged drug release. SMC were cultured from saphenous vein explants obtained from patients undergoing coronary bypass surgery. Cell proliferation was measured by [(3)H]thymidine incorporation. Heparin release from PLGA 50:50 microspheres in an isoosmolar PBS buffer (pH=7.4) showed a triphasic profile with an initial burst (completed after 24 h), a dormant period and a final stage with increased release rate, which lasted about 10-14 days. Cell proliferation as measured by [(3)H]thymidine incorporation was markedly stimulated by platelet-derived growth factor-BB (PDGF-BB) (5 ng/ml) or serum (5%). Proliferation of SMC was equally reduced (50%; P<0.05; n=9-11) by native heparin or heparin released from PLGA microspheres, while PLGA microspheres without heparin loading had no effect on [(3)H]thymidine incorporation in human SMC. Similar results were also obtained when SMC were stimulated with 5% serum instead of PDGF-BB (50%; P<0.05; n=6). Thus, heparin encapsulated into PLGA microspheres was released over a prolonged period of time and thereby effectively reduced human SMC proliferation stimulated either with PDGF or serum. Biodegradable PLGA microspheres may also be used to encapsulate other antiproliferative agents and provide a new approach for local drug delivery after PTCA. This may help to prevent restenosis after PTCA or to reduce graft disease after coronary bypass graft surgery.

Inhibition of Smooth Muscle Cell Adhesion and Proliferation on Heparin-Doped Polypyrrole

Physicochemical and Blood Compatibility Characterization of Polypyrrole Surface Functionalized with Heparin.

Engineering of hemocompatible and antifouling polyethersulfone membranes by blending with heparin-mimicking microgels

Imparting Electroactivity to Polycaprolactone Fibers with Heparin-Doped Polypyrrole: Modulation of Hemocompatibility and Inflammatory Responses.

Facile Preparation of Heparinized Polysulfone Membrane Assisted by Polydopamine/Polyethyleneimine Co-Deposition for Simultaneous Ldl Selectivity and Biocompatibility

Mussel-inspired one-step adherent coating rich in amine groups for covalent immobilization of heparin: hemocompatibility, growth behaviors of vascular cells, and tissue response

Evaluation of Biocompatibility of Polypyrrole in Vitro and in Vivo.

Multifunctional Coatings That Mimic the Endothelium: Surface Bound Active Heparin Nanoparticles with in Situ Generation of Nitric Oxide from Nitrosothiols.

Dopamine-assisted Deposition of Poly (ethylene Imine) for Efficient Heparinization

Heparin-mimicking polyethersulfone membranes – hemocompatibility, cytocompatibility, antifouling and antibacterial properties

Sustained release of heparin from polymeric particles for inhibition of human vascular smooth muscle cell proliferation

Heparin-like surface modification of polyethersulfone membrane and its biocompatibility

Heparin-Controlled Growth of Polypyrrole Nanowires

Development and Processing of Novel Heparin Binding Functionalized Modified Spider Silk Coating for Catheter Providing Dual Antimicrobial and Anticoagulant Properties.

Immobilized Heparin and Its Anti-Coagulation Effect on Polysulfone Membrane Surface

Achieving superior anticoagulation of endothelial membrane mimetic coating by heparin grafting at zwitterionic biocompatible interfaces

Investigation on Clotting and Hemolysis Characteristics of Heparin‐immobilized Polyether Sulfones Biomembrane

Polycarbonate Urethane Films Modified by Heparin to Enhance Hemocompatibility and Endothelialization

Surface Modification of PE Porous Membranes Based on the Strong Adhesion of Polydopamine and Covalent Immobilization of Heparin

Bioinspired Polyethersulfone Membrane Design Via Blending With Functional Polyurethane

Heparin-immobilized polymers as non-inflammatory and non-thrombogenic coating materials for arsenic trioxide eluting stents.